SG11201708698XA - Compositions comprising anakinra - Google Patents
Compositions comprising anakinraInfo
- Publication number
- SG11201708698XA SG11201708698XA SG11201708698XA SG11201708698XA SG11201708698XA SG 11201708698X A SG11201708698X A SG 11201708698XA SG 11201708698X A SG11201708698X A SG 11201708698XA SG 11201708698X A SG11201708698X A SG 11201708698XA SG 11201708698X A SG11201708698X A SG 11201708698XA
- Authority
- SG
- Singapore
- Prior art keywords
- anakinra
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2006—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15165421 | 2015-04-28 | ||
| PCT/EP2016/059398 WO2016174082A1 (en) | 2015-04-28 | 2016-04-27 | Compositions comprising anakinra |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201708698XA true SG11201708698XA (en) | 2017-11-29 |
Family
ID=53015628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201708698XA SG11201708698XA (en) | 2015-04-28 | 2016-04-27 | Compositions comprising anakinra |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11324807B2 (ru) |
| EP (1) | EP3288536B1 (ru) |
| JP (1) | JP6769994B2 (ru) |
| KR (1) | KR102582560B1 (ru) |
| CN (1) | CN107645956B (ru) |
| AU (1) | AU2016256217B2 (ru) |
| CA (1) | CA2983783A1 (ru) |
| DK (1) | DK3288536T3 (ru) |
| ES (1) | ES2744605T3 (ru) |
| IL (1) | IL255275B (ru) |
| MX (1) | MX2017013879A (ru) |
| RU (1) | RU2728795C2 (ru) |
| SG (1) | SG11201708698XA (ru) |
| WO (1) | WO2016174082A1 (ru) |
| ZA (1) | ZA201707872B (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201907137RA (en) * | 2019-08-02 | 2021-03-30 | Singapore Health Serv Pte Ltd | Use of an osmolyte in manufacture of a medicament for treatment of ocular disorders |
| WO2022172284A1 (en) * | 2021-02-11 | 2022-08-18 | Gennova Biopharmaceuticals Ltd. | Purification of a therapeutic protein |
| DE102021212692A1 (de) | 2021-11-11 | 2023-05-11 | Ursapharm Arzneimittel Gmbh | Selbstemulgierende öl-in wasser-mikro- oder nanoemulsion so-wie emulgierende zusammensetzung |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
| US6858409B1 (en) * | 1988-05-27 | 2005-02-22 | Amgen Inc. | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors |
| AU2005231822B2 (en) | 2004-04-02 | 2011-07-21 | Swedish Orphan Biovitrum Ab (Publ) | Methods of reducing aggregation of IL-1ra |
| EP2094306A2 (en) * | 2006-12-20 | 2009-09-02 | XOMA Technology Ltd. | Treatment of il-1-beta related diseases |
| US10105441B2 (en) | 2007-08-16 | 2018-10-23 | The Schepens Eye Research Institute, Inc. | Method for inhibiting or reducing dry eye disease by IL-1Ra |
| WO2009058564A2 (en) * | 2007-11-01 | 2009-05-07 | Maxygen, Inc. | Immunosuppressive polypeptides and nucleic acids |
| ES2962777T3 (es) * | 2007-11-15 | 2024-03-21 | Amgen Inc | Formulación acuosa de anticuerpos estabilizada por antioxidantes para la administración parenteral |
| CN103347533B (zh) * | 2011-02-11 | 2015-12-23 | 瑞典孤儿比奥维特鲁姆有限公司 | 包含阿那白滞素的无柠檬酸盐药物组合物 |
| US20140314746A1 (en) * | 2013-03-13 | 2014-10-23 | Philadelphia Health And Education Corporation, d/b/a Drexel University College of Medicine | Methods for treating or preventing fibrosis in subjects afflicted with scleroderma |
| US20140308239A1 (en) | 2013-03-13 | 2014-10-16 | Eleven Biotherapeutics, Inc. | Chimeric cytokine formulations for ocular delivery |
-
2016
- 2016-04-27 CN CN201680029607.XA patent/CN107645956B/zh active Active
- 2016-04-27 SG SG11201708698XA patent/SG11201708698XA/en unknown
- 2016-04-27 RU RU2017140495A patent/RU2728795C2/ru active
- 2016-04-27 AU AU2016256217A patent/AU2016256217B2/en active Active
- 2016-04-27 EP EP16722558.0A patent/EP3288536B1/en active Active
- 2016-04-27 WO PCT/EP2016/059398 patent/WO2016174082A1/en active Application Filing
- 2016-04-27 US US15/569,659 patent/US11324807B2/en active Active
- 2016-04-27 KR KR1020177034004A patent/KR102582560B1/ko active IP Right Grant
- 2016-04-27 MX MX2017013879A patent/MX2017013879A/es active IP Right Grant
- 2016-04-27 ES ES16722558T patent/ES2744605T3/es active Active
- 2016-04-27 CA CA2983783A patent/CA2983783A1/en not_active Abandoned
- 2016-04-27 DK DK16722558.0T patent/DK3288536T3/da active
- 2016-04-27 JP JP2017556240A patent/JP6769994B2/ja active Active
-
2017
- 2017-10-26 IL IL255275A patent/IL255275B/en active IP Right Grant
- 2017-11-20 ZA ZA2017/07872A patent/ZA201707872B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017022942A2 (pt) | 2018-07-17 |
| WO2016174082A1 (en) | 2016-11-03 |
| MX2017013879A (es) | 2018-08-01 |
| CN107645956A (zh) | 2018-01-30 |
| RU2728795C2 (ru) | 2020-07-31 |
| KR20170142185A (ko) | 2017-12-27 |
| RU2017140495A3 (ru) | 2019-09-13 |
| EP3288536A1 (en) | 2018-03-07 |
| IL255275B (en) | 2020-06-30 |
| RU2017140495A (ru) | 2019-05-28 |
| CN107645956B (zh) | 2021-07-20 |
| US11324807B2 (en) | 2022-05-10 |
| US20180110836A1 (en) | 2018-04-26 |
| EP3288536B1 (en) | 2019-06-26 |
| AU2016256217A1 (en) | 2017-12-07 |
| ZA201707872B (en) | 2020-01-29 |
| JP2018514541A (ja) | 2018-06-07 |
| CA2983783A1 (en) | 2016-11-03 |
| AU2016256217B2 (en) | 2020-04-16 |
| ES2744605T3 (es) | 2020-02-25 |
| IL255275A0 (en) | 2017-12-31 |
| JP6769994B2 (ja) | 2020-10-14 |
| KR102582560B1 (ko) | 2023-09-26 |
| DK3288536T3 (da) | 2019-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201705415YA (en) | Multi-supplement compositions | |
| IL257131A (en) | Preparations | |
| HK1251559A1 (zh) | 普那布林組合物 | |
| GB201512030D0 (en) | Composition | |
| GB201501598D0 (en) | Compositions | |
| GB201505527D0 (en) | Composition | |
| GB201515387D0 (en) | Compositions | |
| GB201506827D0 (en) | Composition | |
| GB201515391D0 (en) | Compositions | |
| GB201506829D0 (en) | Composition | |
| GB201506825D0 (en) | Composition | |
| GB201506830D0 (en) | Composition | |
| SI3349766T1 (sl) | Antihemoragični sestavki | |
| ZA201707872B (en) | Compositions comprising anakinra | |
| GB201506828D0 (en) | Composition | |
| GB201511697D0 (en) | Composition | |
| GB201509044D0 (en) | Composition | |
| GB201505520D0 (en) | Composition | |
| GB201504665D0 (en) | Composition | |
| GB201504307D0 (en) | Composition | |
| GB2538335B (en) | Compositions | |
| GB201508722D0 (en) | Composition | |
| GB201506826D0 (en) | Composition | |
| PL3393503T3 (pl) | Kompozycje | |
| GB201509641D0 (en) | Composition |